Sea Bridge Investment Advisors LLC Bristol Myers Squibb CO Transaction History

Sea Bridge Investment Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $7,869 - $9,436	-128 Reduced 3.74%	3,294 $241,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $183,521 - $213,943	3,422 New	3,422 $213,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $198,988 - $233,089	-3,363 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $199,560 - $224,446	3,363 New	3,363 $212,000
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $182,631 - $206,955	-3,163 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$57.43 - $63.64 $34,458 - $38,184	600 Added 23.41%	3,163 $191,000
Q4 2019 Feb 03, 2020	BUY	$49.21 - $64.19 $21,160 - $27,601	430 Added 20.16%	2,563 $165,000
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $21,385 - $25,355	500 Added 30.62%	2,133 $108,000
Q2 2019 Jul 18, 2019	BUY	$44.62 - $49.34 $31,234 - $34,538	700 Added 75.03%	1,633 $74,000
Q1 2019 Apr 30, 2019	BUY	$45.12 - $53.8 $13,536 - $16,140	300 Added 47.39%	933 $45,000
Q4 2017 Jan 23, 2018	BUY	$59.94 - $65.35 $19,960 - $21,761	333 Added 111.0%	633 $39,000
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $16,569 - $19,122	300	300 $19,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sea Bridge Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Bridge Investment Advisors LLC with notifications on news.